Psoriasis therapy holds promise for treating atherosclerosis: study
The findings reinforce the importance of treating inflammation, including of the skin, say researchers
Biologic therapy in patients with severe psoriasis is associated with significant improvements in coronary-artery plaque characteristics, according to new research.
Lead author Dr Nehal Mehta from the National Heart, Lung and Blood Institute in Maryland, US, says the anti-inflammatory effects of biologic therapies hold promise for the treatment of atherosclerosis, but more research is needed.
